Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|September 17, 2019
The sialoglycan-Siglec glyco-immune checkpoint - a target for improving innate and adaptive anti-cancer immunityAnne Bärenwaldt, Heinz LäubliJournal of Immunology (Baltimore, Md. : 1950)|April 18, 2018
NKp46 Calibrates Tumoricidal Potential of Type 1 Innate Lymphocytes by Regulating TRAIL ExpressionGleb Turchinovich, Stefan Ganter, Anne Bärenwaldt, et al.Environmental Science & Technology|November 22, 2005
Humic material induces behavioral and global transcriptional responses in the nematode Caenorhabditis elegansRalph Menzel, Stephen Stürzenbaum, Anne Bärenwaldt, et al.Frontiers in Immunology|May 1, 2023
Changes of peripheral T cell subsets in melanoma patients with immune-related adverse eventsBenjamin Müller, Anne Bärenwaldt, Petra Herzig, et al.Angewandte Chemie (International Ed. in English)|November 10, 2023
Tetra- and Hexavalent Siglec-8 Ligands Modulate Immune Cell ActivationGabriele Conti, Anne Bärenwaldt, Said Rabbani, et al.Frontiers in Cell and Developmental Biology|March 21, 2022
Siglec Receptors Modulate Dendritic Cell Activation and Antigen Presentation to T Cells in CancerJinyu Wang, Michela Manni, Anne Bärenwaldt, et al.PNAS Nexus|November 11, 2025
Increase of Inhibitory Siglec receptors on T cells mitigates severe immune reactions during acute viral infectionsNatalia Rodrigues Mantuano, Anne Bärenwaldt, Mirza Sarcevic, et al.Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
A Th17 signature correlates with response to dual CTLA-4 and PD-1 blockade in metastatic renal cell carcinomaSilvia Guglietta, Anne Bärenwaldt, Anthony Sonrel, et al.Science Translational Medicine|November 2, 2022
Targeting cancer glycosylation repolarizes tumor-associated macrophages allowing effective immune checkpoint blockadeMichal A Stanczak, Natalia Rodrigues Mantuano, Nicole Kirchhammer, et al.Pageof 1